Healthcare Strategy Group

medical techniques Group makes use of the expertise of Dr Iain Miller and his system of expert providers and associates to aid life science and med-tech strategic initiatives and business development for diverse clients. The core focus part of the team is commercial development of precision medicine.

Iain Miller, creator of medical techniques Group (HSG), is a health method and commercial development exec with nearly 25 years of diverse medical technology knowledge attained in a number of settings and geographies. Iain also sits on Board regarding the European Personalized Medicine Association and it is a member of tech Appraisal Committee of NICE in the UK.

Ahead of founding HSG in 2013, Iain served with GE Healthcare as international mind of personal Healthcare Technique & Partnerships. Previously, at bioMerieux, Iain ended up being responsible for oncology strategy also led method and company development the Personalized drug Business Unit. Before GE medical and Biomerieux, Iain held leadership roles in two venture-backed genomics businesses (Pathogenetix, previously United States Genomics, one molecule sequencing system business and Variagenics, a pharmacogenomics CRO). Iain in addition presented a technology transfer administrator part at Massachusetts General Hospital in Boston and had been founder of Derma-Lase, that was later acquired by Candela/Syneron. In addition to the foregoing companies and establishments, Dr. Miller has consulted for organizations including Myriad Genetics, Philips medical, J&J, Abbott Diagnostics and Oxford Immunotec.

Throughout their career, Iain has actually dedicated to commercial development in the diagnostics, and unit sectors. He's an accepted international idea leader in the high-growth personalized medicine marketplace with a dynamic part in a number of worldwide policy market access projects and reputation for successful execution of deals supporting enhanced drug development and commercialization. He's a powerful track record of working management and multi-functional responsibility including strategy, company development, regulating affairs management, item development and R&D portfolio management, and a history of entrepreneurial success. Their extensive intercontinental knowledge includes twenty years surviving in the United States. Within the nonprofit medical technology area, Iain is a co-founder and active Board member of EPEMED, the European Personalized medication Association, sits regarding Oxford Bioscience Network Advisory Board, and is co-author of a number of pending plan white documents on market access for diagnostic products. Within EPEMED, he sat on the oversight committee of this report “Personalised medication in European countries: Enhancing Patient accessibility Drug-Diagnostic Companion Products”, which published in September 2014. Iain additionally recently served from the oversight committee of UK Academy of healthcare Sciences Stratified drug task, culminating in a 90-page policy report in July, 2013 “Realising the possibility fof stratified medicine”.

On a task foundation, Dr. Miller lovers with intercontinental colleagues to provide full service health-economic modelling and researching the market.